Valuation: BioArctic AB

Capitalization 2.83TCr 300.37Cr 258.2Cr 241.88Cr 225.45Cr 416.41Cr 27TCr 452.93Cr 1.09TCr 13TCr 1.13TCr 1.1TCr 47TCr P/E ratio 2025 *
27.8x
P/E ratio 2026 * 96.3x
Enterprise value 2.63TCr 278.83Cr 239.68Cr 224.53Cr 209.28Cr 386.55Cr 25TCr 420.45Cr 1.01TCr 12TCr 1.05TCr 1.02TCr 43TCr EV / Sales 2025 *
13x
EV / Sales 2026 * 22x
Free-Float
44.08%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.51%
1 week+0.98%
Current month+0.98%
1 month+13.93%
3 months+6.00%
6 months+52.88%
Current year+54.19%
More quotes
1 week 287.8
Extreme 287.8
321
1 month 257
Extreme 257
321
Current year 154.4
Extreme 154.4
342.8
1 year 154.4
Extreme 154.4
342.8
3 years 137.7
Extreme 137.7
392
5 years 66.7
Extreme 66.7
392
10 years 20.4
Extreme 20.4
392
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2013
Director of Finance/CFO 54 01/06/2023
Chief Tech/Sci/R&D Officer 53 01/01/2012
Director TitleAgeSince
Director/Board Member 78 24/01/2003
Chairman 76 28/01/2003
Chairman 71 01/06/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.69%+0.98%+65.47%-1.09% 300.72Cr
-0.95%-1.24%+4.46%+9.05% 4.8TCr
+0.18%-2.13%+12.59%+6.22% 3.83TCr
-3.12%-5.38%+59.82%+70.79% 3.67TCr
+0.38%-1.03%+9.38%+19.64% 2.71TCr
-0.17%-8.36%+58.61%+164.20% 1.53TCr
+1.04%+1.94%+67.59%+225.95% 1.52TCr
+0.06%+0.23%-11.49%-9.45% 1.42TCr
+0.73%-1.30%+44.69% - 1.36TCr
-0.45%-1.56%+121.61%+108.93% 1.33TCr
Average -0.53%-1.38%+43.27%+66.03% 2.25TCr
Weighted average by Cap. -0.54%-1.69%+32.59%+52.37%
See all sector performances

Financials

2025 *2026 *
Net sales 201.51Cr 21Cr 18Cr 17Cr 16Cr 30Cr 1.93TCr 32Cr 78Cr 909.38Cr 80Cr 79Cr 3.33TCr 120.46Cr 13Cr 11Cr 10Cr 9.6Cr 18Cr 1.15TCr 19Cr 47Cr 543.59Cr 48Cr 47Cr 1.99TCr
Net income 100.47Cr 11Cr 9.17Cr 8.59Cr 8.01Cr 15Cr 960Cr 16Cr 39Cr 453.4Cr 40Cr 39Cr 1.66TCr 29Cr 3.12Cr 2.68Cr 2.51Cr 2.34Cr 4.33Cr 281.05Cr 4.71Cr 11Cr 132.74Cr 12Cr 11Cr 485.34Cr
Net Debt -202.87Cr -22Cr -19Cr -17Cr -16Cr -30Cr -1.94TCr -32Cr -78Cr -915.53Cr -81Cr -79Cr -3.35TCr -180.08Cr -19Cr -16Cr -15Cr -14Cr -27Cr -1.72TCr -29Cr -70Cr -812.67Cr -72Cr -70Cr -2.97TCr
More financial data * Estimated data
Logo BioArctic AB
BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.
Employees
122
More about the company
Date Price Change Volume
05/25/05 307.60 kr -3.69% 1,48,657
04/25/04 319.40 kr +4.24% 3,18,641
03/25/03 306.40 kr +0.79% 1,66,226
02/25/02 304.00 kr +3.97% 1,92,995
01/25/01 292.40 kr -4.01% 1,83,261

Delayed Quote Nasdaq Stockholm, December 05, 2025 at 10:30 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
319.40SEK
Average target price
295.60SEK
Spread / Average Target
-7.45%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIOA B Stock